Asthma is a complex inflammatory condition that afflicts 10-15 million people in the US alone. Asthma and its related phenotypes (airway hyper responsiveness (AHR), atopy and airway inflammation) have a heritable component. Despite this recognition, the genetic mechanism underlying susceptibility to asthma and asthma-related phenotypes remain unknown. Identification of susceptibility genes for human asthma has been hampered by variability in clinical phenotype, genetic heterogeneity in human populations and experimental difficulty in addressing the molecular mechanism underlying complex pathological processes in humans. Thus our strategy is to take advantage of the genetic and experimental tractability of inbred murine models of asthma to provide high quality positional candidates for human genetic studies. Using classic genetic analysis and gene profiling techniques, we have identified complement factor 5 (C5) as a strong positional candidate for one of the two distinct QTLs identified for AHR in the murine model. We provide evidence that an allelic variant in the C5 locus is closely associated with susceptibility to AHR in this murine model. Mechanistically, our preliminary data suggest that expression of the variant allele results in a defective C5 protein leading to impaired IL-12 production and consequent up regulation of Th2 cytokines and AHR. Further support for this possible importance of this locus to asthma is the fact that our collaborators have reported linkage of asthma to the syntenic region of C5 in humans (chr 9q). Thus we plan to critically examine the hypothesis that polymorphism(s) in the C5 region or related genes contribute to the development of asthma or asthma related phenotypes in mice and humans.
Our specific aims are (1) to identify additional positional candidate genes for the allergen induced AHR phenotypes from the larger number of candidate genes identified by linkage analysis and preliminary expression studies, we will determine transcription and translation kinetics for positional candidate genes and search for polymorphisms in differentially regulated genes (2) to investigate the role of C5 in susceptibility to AHR, we will manipulate C5 levels in vivo, explore the relationship between C5 expression and AHR in mice with functionally different C5 alleles and explore interactions between C5 and other linked positional candidate genes (3) to determine the mechanism by which altered C5 expression confers susceptibility to AHR, we will test the hypothesis that C5 expression regulates production of the critical Th-1 inducing cytokine IL-12 leading to skewed T cell responses to allergen exposure and subsequent development of AHR (4) to test for association of any identified sequence variants with AHR, elevated total serum IgE and asthma. We will confirm our findings in two additional groups of asthmatics (1) a Caucasian population on Tangier Island, VA and (2) and Afro-Caribbean population from Barbados. This combined (mouse and human) approach to the study of asthma genetics should provide insight into the genes controlling susceptibility to human asthma and promote the development of novel therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067736-05
Application #
6788107
Study Section
Special Emphasis Panel (ZHL1-CSR-L (S1))
Program Officer
Banks-Schlegel, Susan P
Project Start
2000-09-30
Project End
2005-11-30
Budget Start
2004-09-01
Budget End
2005-11-30
Support Year
5
Fiscal Year
2004
Total Cost
$448,301
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
McAlees, Jaclyn W; Lajoie, Stephane; Dienger, Krista et al. (2015) Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma. Eur J Immunol 45:1019-29
Lajoie, S; Lewkowich, I; Herman, N S et al. (2014) IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin Exp Allergy 44:976-85
Lewkowich, I P; Lajoie, S; Stoffers, S L et al. (2013) PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production. Mucosal Immunol 6:728-39
Wills-Karp, Marsha; Rani, Reena; Dienger, Krista et al. (2012) Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J Exp Med 209:607-22
Schauberger, Eric M; Ewart, Susan L; Arshad, Syed H et al. (2011) Identification of ATPAF1 as a novel candidate gene for asthma in children. J Allergy Clin Immunol 128:753-760.e11
Wang, Yui-Hsi; Wills-Karp, Marsha (2011) The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep 11:388-94
Chen, Gang; Wan, Huajing; Luo, Fengming et al. (2010) Foxa2 programs Th2 cell-mediated innate immunity in the developing lung. J Immunol 184:6133-41
Lajoie, Stephane; Lewkowich, Ian P; Suzuki, Yusuke et al. (2010) Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11:928-35
Wills-Karp, M; Nathan, A; Page, K et al. (2010) New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 3:104-10
Page, Kristen; Ledford, John R; Zhou, Ping et al. (2010) Mucosal sensitization to German cockroach involves protease-activated receptor-2. Respir Res 11:62

Showing the most recent 10 out of 33 publications